Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Gastroenterology|May 19, 2009
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trialJames E Everhart, Anna S Lok, Hae-Young Kim, et al.
Gastroenterology|January 4, 2003
Progression of fibrosis in chronic hepatitis CMarc G Ghany, David E Kleiner, Harvey Alter, et al.
Hepatology (Baltimore, Md.)|September 22, 2015
Diabetes and prediabetes in patients with hepatitis B residing in North AmericaMandana Khalili, Manuel Lombardero, Raymond T Chung, et al.
The American Journal of Gastroenterology|December 9, 2010
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infectionRobert J Fontana, David E Kleiner, Richard Bilonick, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 16, 2026
IFNL4 Genotype is Associated with Hepatitis A Virus InfectionFindings from a Focused Phenotype Study in the UK Biobank CohortNeha Agarwala, Minkyo Song, Marc G Ghany, et al.
Antiviral Research|May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 yearsPallavi Surana, Devika Kapuria, Carly Broadwell, et al.
Hepatology (Baltimore, Md.)|August 5, 2015
Present and future therapies of hepatitis B: From discovery to cureT Jake Liang, Timothy M Block, Brian J McMahon, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2016
Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis CNiharika Samala, Elizabeth C Wright, A Gretchen Buckler, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Gastroenterology|May 19, 2009
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trialJames E Everhart, Anna S Lok, Hae-Young Kim, et al.
Gastroenterology|January 4, 2003
Progression of fibrosis in chronic hepatitis CMarc G Ghany, David E Kleiner, Harvey Alter, et al.
Hepatology (Baltimore, Md.)|September 22, 2015
Diabetes and prediabetes in patients with hepatitis B residing in North AmericaMandana Khalili, Manuel Lombardero, Raymond T Chung, et al.
The American Journal of Gastroenterology|December 9, 2010
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis CRobert J Fontana, Arun J Sanyal, Marc G Ghany, et al.
Hepatology (Baltimore, Md.)|September 29, 2006
Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infectionRobert J Fontana, David E Kleiner, Richard Bilonick, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 16, 2026
IFNL4 Genotype is Associated with Hepatitis A Virus InfectionFindings from a Focused Phenotype Study in the UK Biobank CohortNeha Agarwala, Minkyo Song, Marc G Ghany, et al.
Antiviral Research|May 25, 2019
Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 yearsPallavi Surana, Devika Kapuria, Carly Broadwell, et al.
Hepatology (Baltimore, Md.)|August 5, 2015
Present and future therapies of hepatitis B: From discovery to cureT Jake Liang, Timothy M Block, Brian J McMahon, et al.
Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2016
Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis CNiharika Samala, Elizabeth C Wright, A Gretchen Buckler, et al.
Pageof 19